Vebicorvir (ABI-H0731) is a first-generation HBV core protein allosteric modulator that potently inhibits viral replication. It has demonstrated significant antiviral activity in both in vitro assays and in vivo preclinical studies, supporting its investigation as a potential therapeutic agent for chronic hepatitis B.